B. Rizzacasa

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies

Elena Morini, G. Novelli, F. Amati, 2017, International journal of molecular sciences.

Low molecular weight heparin -induced miRNA changes in peripheral blood mononuclear cells in pregnancies with unexplained recurrent pregnancy loss.

B. Rizzacasa, J. Ernerudh, E. Ferretti, 2022, Journal of reproductive immunology.

Breast cancer in Western Africa: A pilot molecular analysis of BRCA genes in early- onset breast cancer patients in Burkina Faso

G. Novelli, B. Rizzacasa, A. Latini, 2021 .

Epigenetic Modification in Coronary Atherosclerosis: JACC Review Topic of the Week.

J. Mehta, G. Novelli, F. Amati, 2019, Journal of the American College of Cardiology.

Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso

G. Novelli, B. Rizzacasa, A. Latini, 2021, Human Genomics.

MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study

R. Mango, G. Novelli, F. Amati, 2019, PloS one.

Inhibition of HECT E3 ligases as potential therapy for COVID-19

P. Pandolfi, J. Casanova, L. Notarangelo, 2021, Cell Death & Disease.

OLR1 and Loxin Expression in PBMCs of Women with a History of Unexplained Recurrent Miscarriage: A Pilot Study.

G. Novelli, F. Amati, B. Rizzacasa, 2017, Genetic Testing and Molecular Biomarkers.